Hanglok completed A round of financing of more than 200 million yuan. This round of financing was led by Daohe Healthcare, followed by Proxima Ventures, Yuansheng BioVenture, Huatai Zijin, Lvyong Ruihua, Kangze(Macau) and long-time shareholder GREE Capital. The financing will be used for clinical trials, registration and application of puncture surgical robot products, team building, market expansion and pipeline product research and development, and to accelerate the development and commercialization of surgical robot products.